FOLH1 and prostate cancer: In this study, the clinical feasibility of AuNP radiosensitization on prostate cancer was investigated through in vitro and in silico experiments by quantifying radiosensitization of PSMA-targeted AuNPs under 6 MV irradiation at various clinically relevant depths.